These Quality Stocks Look Really Cheap. This Could Be Their Year.
After getting thrashed by low-quality stocks in 2025, high-quality names should outperform in 2026.
This Calculator Shows the Biggest Risk Factors for Heart Disease. It Might Surprise You.
The revamped American Heart Association tool offers a surprising look at the issues that make cardiovascular disease the country’s top killer.
Salesforce Is Ready to Emerge an AI Winner. Buy the Stock.
The company has unfairly received the label of AI loser. That should change, and soon.
Fidelity Contrafund’s Will Danoff Is Getting Closer to Handing Over the Reins
The legendary manager has taken on two co-managers to help him run the mammoth fund. Just don’t use the word “retirement.”
Timeshares Have Made a Comeback. Can Their Stocks?
Once tarred as an unwise investment at best, fractional ownership has a new set of fans.
This Tech Investor Likes Broadcom, Bloom Energy, and Other AI Bargains
Paul Wick of Seligman Investments has piloted his winning fund through numerous technology cycles. How he is playing AI, and why he is skeptical of quantum computing stocks.
Boomers Daily 